Back
Neumora Therapeutics 10K Form
Sell
11
NMRA
Neumora Therapeutics
Last Price:
$0.71
Seasonality Move:
3.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NMRA News And Ratings
See the #1 stock for the next 7 days that we like better than NMRA
NMRA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-50.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.78 |
| Price / Book: | 0.37 |
Profitability
| EPS (TTM): | -1.53000 |
|---|---|
| Net Income (TTM): | $-243.8M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Neumora Therapeutics Earnings Forecast
Key Neumora Therapeutics Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Neumora Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NMRA |
| Website: | neumoratx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NMRA Technical Analysis vs Fundamental Analysis
Sell
11
Neumora Therapeutics (NMRA)
is a Sell
Is Neumora Therapeutics a Buy or a Sell?
-
Neumora Therapeutics stock is rated a SellThe current Neumora Therapeutics [NMRA] share price is $0.66. The Score for NMRA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.